CARGO Therapeutics, Inc. (CRGX)
Data as of , from SEC Form 4 filings.
See up to 3 months of CRGX. The 7-day demo opens the 1M and 3M ranges and puts CRGX on your watchlist.
Start 7-day demoLatest CRGX insider trades
About CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics, Inc. files with the SEC under CIK 0001966494 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
CRGX Form 4 activity by transaction type, last 90 days
No Form 4 activity for CRGX in the last 90 days.
CRGX insider transactions (Form 4)
1410 Form 4 filings on record, the earliest from Nov 15, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Krishnan Viswanadhan | Derivative | Stock Option (Right to Buy) | 3,173 | - | - | |
| Krishnan Viswanadhan | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Abraham Bassan | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Reid M. Huber | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| David Charles Lubner | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| John A. Orwin | Derivative | Stock Option (Right to Buy) | 15,865 | - | - | |
| John A. Orwin | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
 Kapil Dhingra | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
 Jane Henderson | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Anup Radhakrishnan - Officer | Other | Common Stock | 57,345 | $4.38 | $251K | |
| Anup Radhakrishnan - Officer | Derivative | Common Stock | 63,436 | $4.38 | $278K | |
| Anup Radhakrishnan - Officer | Derivative | Stock Option (Right to Buy) | 14,679 | - | - | |
| Anup Radhakrishnan - Officer | Open-market sale | Common Stock | 1,632 | $4.18 | $7K | |
| Anup Radhakrishnan - Officer | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - |
CRGX insider trading FAQ
What is the latest insider trade for CRGX?
CARGO Therapeutics, Inc. (CRGX) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-19. The full record for CRGX runs to 10 Form 4 filings, the earliest from 2024-11-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRGX stock?
No insider purchases of CRGX were filed in the last 90 days.
How many insiders are selling CRGX stock?
No insider sales of CRGX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see CRGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRGX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Krishnan Viswanadhan view on EDGAR
- - Abraham Bassan view on EDGAR
- - Reid M. Huber view on EDGAR
- - David Charles Lubner view on EDGAR
- - John A. Orwin view on EDGAR
- - Kapil Dhingra view on EDGAR
- - Jane Henderson view on EDGAR
- - Anup Radhakrishnan view on EDGAR
- - Anup Radhakrishnan view on EDGAR
- - Anup Radhakrishnan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CRGX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRGX with a 7-day demo
- CRGX on your watchlist
- Every CRGX Form 4 filing on record
- Up to 3 months of CRGX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
